BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32176886)

  • 1. Early Detection of Sporadic Pancreatic Ductal Adenocarcinoma: Problems, Promise, and Prospects.
    Chari ST; Sharma A; Maitra A
    Ann Intern Med; 2020 Apr; 172(8):558-559. PubMed ID: 32176886
    [No Abstract]   [Full Text] [Related]  

  • 2. Circulating Exosomes in Pancreatic Cancer: Will They Succeed on the Long, Littered Road to Early Detection Marker?
    Babic A; Wolpin BM
    Clin Chem; 2016 Feb; 62(2):307-9. PubMed ID: 26721295
    [No Abstract]   [Full Text] [Related]  

  • 3. Early detection and imaging strategies to reveal and target developing pancreatic cancer.
    Crawford HC; Wallace MB; Storz P
    Expert Rev Anticancer Ther; 2020 Feb; 20(2):81-83. PubMed ID: 31986932
    [No Abstract]   [Full Text] [Related]  

  • 4. Screening for Pancreatic Cancer.
    Wada K; Takaori K; Traverso LW
    Surg Clin North Am; 2015 Oct; 95(5):1041-52. PubMed ID: 26315522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for Pancreatic Cancer: Recommendation Statement.
    Am Fam Physician; 2019 Dec; 100(12):Online. PubMed ID: 31845783
    [No Abstract]   [Full Text] [Related]  

  • 6. Potential biomarkers for early detection of pancreatic ductal adenocarcinoma.
    Kriz D; Ansari D; Andersson R
    Clin Transl Oncol; 2020 Dec; 22(12):2170-2174. PubMed ID: 32447642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Detection of Pancreatic Cancer: Opportunities and Challenges.
    Singhi AD; Koay EJ; Chari ST; Maitra A
    Gastroenterology; 2019 May; 156(7):2024-2040. PubMed ID: 30721664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevating pancreatic cystic lesion stratification: Current and future pancreatic cancer biomarker(s).
    Carmicheal J; Patel A; Dalal V; Atri P; Dhaliwal AS; Wittel UA; Malafa MP; Talmon G; Swanson BJ; Singh S; Jain M; Kaur S; Batra SK
    Biochim Biophys Acta Rev Cancer; 2020 Jan; 1873(1):188318. PubMed ID: 31676330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Markers of pancreatic cancer: working toward early detection.
    Goggins M
    Clin Cancer Res; 2011 Feb; 17(4):635-7. PubMed ID: 21304000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticle-enabled blood tests for early detection of pancreatic ductal adenocarcinoma.
    Caputo D; Caracciolo G
    Cancer Lett; 2020 Feb; 470():191-196. PubMed ID: 31783084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters.
    Urayama S
    World J Gastroenterol; 2015 Feb; 21(6):1707-17. PubMed ID: 25684935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic ductal adenocarcinoma screening: new perspectives.
    Pezzilli R; Fabbri D; Imbrogno A
    World J Gastroenterol; 2012 Sep; 18(36):4973-7. PubMed ID: 23049204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urine test can detect early stage pancreatic cancer.
    Bagcchi S
    Lancet Oncol; 2015 Sep; 16(9):e431. PubMed ID: 26256762
    [No Abstract]   [Full Text] [Related]  

  • 14. Glycoprotein biomarkers for the detection of pancreatic ductal adenocarcinoma.
    Llop E; E Guerrero P; Duran A; Barrabés S; Massaguer A; José Ferri M; Albiol-Quer M; de Llorens R; Peracaula R
    World J Gastroenterol; 2018 Jun; 24(24):2537-2554. PubMed ID: 29962812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic cancer and cancer screening programs: from nihilism to hope.
    Pezzilli R; Corinaldesi R; Morselli-Labate AM
    JOP; 2010 Nov; 11(6):654-5. PubMed ID: 21068511
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.
    Mayerle J; Kalthoff H; Reszka R; Kamlage B; Peter E; Schniewind B; González Maldonado S; Pilarsky C; Heidecke CD; Schatz P; Distler M; Scheiber JA; Mahajan UM; Weiss FU; Grützmann R; Lerch MM
    Gut; 2018 Jan; 67(1):128-137. PubMed ID: 28108468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can circulating tumor and exosomal nucleic acids act as biomarkers for pancreatic ductal adenocarcinoma?
    Liu DSK; Mato Prado M; Giovannetti E; Jiao LR; Krell J; Frampton AE
    Expert Rev Mol Diagn; 2019 Jul; 19(7):553-558. PubMed ID: 31159604
    [No Abstract]   [Full Text] [Related]  

  • 18. Optimization of Pancreatic Juice Collection: A First Step Toward Biomarker Discovery and Early Detection of Pancreatic Cancer.
    Levink IJM; Nesteruk K; Visser DI; Sieuwerts AM; Fernandes CJC; Jansen MPHM; van Driel LMJW; Poley JW; Peppelenbosch MP; Cahen DL; Fuhler GM; Bruno MJ
    Am J Gastroenterol; 2020 Dec; 115(12):2103-2108. PubMed ID: 33105193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early detection of sporadic pancreatic cancer: summative review.
    Chari ST; Kelly K; Hollingsworth MA; Thayer SP; Ahlquist DA; Andersen DK; Batra SK; Brentnall TA; Canto M; Cleeter DF; Firpo MA; Gambhir SS; Go VL; Hines OJ; Kenner BJ; Klimstra DS; Lerch MM; Levy MJ; Maitra A; Mulvihill SJ; Petersen GM; Rhim AD; Simeone DM; Srivastava S; Tanaka M; Vinik AI; Wong D
    Pancreas; 2015 Jul; 44(5):693-712. PubMed ID: 25931254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early detection of sporadic pancreatic cancer: strategic map for innovation--a white paper.
    Kenner BJ; Chari ST; Cleeter DF; Go VL
    Pancreas; 2015 Jul; 44(5):686-92. PubMed ID: 25938853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.